Case Report
BibTex RIS Cite

Rhabdomyolysis after suicide attempt with escitalopram and enalapril

Year 2017, Volume: 56 Issue: 3, 151 - 153, 01.09.2017
https://doi.org/10.19161/etd.393483

Abstract

Rhabdomyolysis is a clinical syndrome characterized by muscle necrosis and the release of intracellular muscle ingredients into the blood circulation. The most serious complication is acute kidney injury. Rhabdomyolysis may occur due to various etiological factors. The most common reasons are crush injuries to muscle, excessive exercise, inflammatory muscle diseases, prolonged immobility, electrolyte imbalances and drug toxicity. The clinicians should be aware for rhabdomyolysis and its possible complications in drug poisoning cases. Enalapril may cause electrolyte imbalance and escitalopram may cause serotonin syndrome resulting rhabdomyolysis. In this paper we present a previously healthy fifteen years old girl, who developed rhabdomyolysis without electrolyte imbalance or neuroleptic syndrome after intake of enalapril and escitalopram for suicide attempt. A large number of drugs can cause rhabdomyolysis by different mechanisms. It should be kept in mind that the some drugs can cause rhabdomyolysis without causing significant clinical changes.

References

  • Melli G, Chaudhry V, Cornblath DR. Rhabdomyolysis: An evaluation of 475 hospitalized patients. Medicine 2005;84(6):377-85.
  • Huerta-Alardin AL, Varon J, Marik PE. Rhabdomyolysis an overview for clinicians. Crit Care 2005;9(2):158-69.
  • Giannoglou GD, Chatzizisis YS, Misirli G. The syndrome of rhabdomyolysis: Pathophysiology and diagnosis. Eur J Intern Med 2007;18(2):90-100.
  • Al-Ismaili Z, Piccioni M, Zappitelli M. Rhabdomyolysis: Pathogenesis of renal injury and management. Pediatr Nephrol 2011;26(10):1781-8.
  • Elsayed EF, Reilly RF. Rhabdomyolysis: A review, with emphasis on the pediatric population. Pediatr Nephrol 2010;25(1):7-18.
  • Watanabe T. Rhabdomyolysis and acute renal failure in children. Pediatr Nephrol 2001;16(12):1072-5.
  • Luck RP, Verbin S. Rhabdomyolysis: A review of clinical presentation, etiology, diagnosis, and management. Pediatr Emerg Care 2008;24(4):262-8.
  • Mannix R, Tan ML, Wright R, Baskin M. Acute pediatric rhabdomyolysis: Causes and rates of renal failure. Pediatrics 2006;118(5):2119-25.
  • Veenstra J, Smit WM, Krediet RT, Arisz L. Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis. Nephrol Dial Transplant 1994;9(6):637-41.
  • Oshima Y. Characteristics of drug-associated rhabdomyolysis: Analysis of 8,610 cases reported to the U.S. Food and Drug Administration. Intern Med 2011;50(8):845-53.

Enalapril ve essitalopram ile özkıyım girişimi sonrası gelişen rabdomiyoliz

Year 2017, Volume: 56 Issue: 3, 151 - 153, 01.09.2017
https://doi.org/10.19161/etd.393483

Abstract

Rabdomiyoliz, kas nekrozu sonucu kas içi içeriğin kan dolaşımına çıkması ile gelişen klinik bir sendromdur. En önemli komplikasyonu akut böbrek hasarıdır. Rabdomiyoliz çok değişik etiyolojik faktörlere bağlı olarak ortaya çıkabilir. En sık nedenler ise travma, aşırı egzersiz, inflamatuar kas hastalıkları, uzun süren hareketsizlik, elektrolit dengesizlikleri ve ilaç toksisitesidir. İlaç zehirlenmelerinde rabdomiyoliz ve olası komplikasyonları açısından dikkatli olunmalıdır. Enalapril elektrolit dengesizliğine neden olarak, essitalopram ise serotonin sendromuna yol açarak olarak rabdomiyolize neden olabilir. Bu yazıda elektrolit bozukluğu veya nöroleptik sendrom gelişmeden, özkıyım amacı ile enalapril ve essitalopram alımı sonrası ılımlı rabdomiyoliz gelişen, öncesinde sağlıklı on beş yaşındaki bir kız çocuğu sunulmuştur. İlaçlar farklı mekanizmalar ile rabdomiyolize neden olabilir. Bazı ilaçların önemli klinik değişliklere yol açmadan da rabdomiyolize neden olabileceği akılda tutulmalıdır.

References

  • Melli G, Chaudhry V, Cornblath DR. Rhabdomyolysis: An evaluation of 475 hospitalized patients. Medicine 2005;84(6):377-85.
  • Huerta-Alardin AL, Varon J, Marik PE. Rhabdomyolysis an overview for clinicians. Crit Care 2005;9(2):158-69.
  • Giannoglou GD, Chatzizisis YS, Misirli G. The syndrome of rhabdomyolysis: Pathophysiology and diagnosis. Eur J Intern Med 2007;18(2):90-100.
  • Al-Ismaili Z, Piccioni M, Zappitelli M. Rhabdomyolysis: Pathogenesis of renal injury and management. Pediatr Nephrol 2011;26(10):1781-8.
  • Elsayed EF, Reilly RF. Rhabdomyolysis: A review, with emphasis on the pediatric population. Pediatr Nephrol 2010;25(1):7-18.
  • Watanabe T. Rhabdomyolysis and acute renal failure in children. Pediatr Nephrol 2001;16(12):1072-5.
  • Luck RP, Verbin S. Rhabdomyolysis: A review of clinical presentation, etiology, diagnosis, and management. Pediatr Emerg Care 2008;24(4):262-8.
  • Mannix R, Tan ML, Wright R, Baskin M. Acute pediatric rhabdomyolysis: Causes and rates of renal failure. Pediatrics 2006;118(5):2119-25.
  • Veenstra J, Smit WM, Krediet RT, Arisz L. Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis. Nephrol Dial Transplant 1994;9(6):637-41.
  • Oshima Y. Characteristics of drug-associated rhabdomyolysis: Analysis of 8,610 cases reported to the U.S. Food and Drug Administration. Intern Med 2011;50(8):845-53.
There are 10 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Journal Section Case Reports
Authors

Sinan Oğuz 0000-0002-6700-6525

Nilden Tuygun 0000-0002-5359-4215

Can Demir Karacan 0000-0001-5301-8106

Publication Date September 1, 2017
Submission Date June 26, 2016
Published in Issue Year 2017Volume: 56 Issue: 3

Cite

Vancouver Oğuz S, Tuygun N, Karacan CD. Enalapril ve essitalopram ile özkıyım girişimi sonrası gelişen rabdomiyoliz. EJM. 2017;56(3):151-3.